Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Primary Objective:
The primary objective of this study is to develop and validate a clinical risk index score for identifying NSTIs in emergency general surgery patients being evaluated for a severe skin and soft tissue infection.
Secondary Objectives:
To describe the contemporary microbiology of NSTIs and explore the effects on outcomes and to identify predictors of amputation and mortality.
This study is designed as a multicenter, prospective, observational study. There will be no direct interaction with subjects and involves no interventions; study is conducted completely via review of electronic health records. Our site will only collect data from the Methodist Dallas Medical Center. We plan to complete the data collection and analysis by 12/30/2021.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Necrotizing soft tissue infections (NSTIs) | Other | There will be no direct interaction with subjects and involves no interventions; study is conducted completely via review of electronic health records. Our site will only collect data from the Methodist Dallas Medical Center. |
| Measure | Description | Time Frame |
|---|---|---|
| Change in the presence of necrosis | presence of necrosis-"dishwater" fluid or deliquescent tissues | up to 30 days |
| Change in the presence of necrosis | thrombosed vessels or absence of bleeding | up to 30 days |
| mortality length of time in hospital | 30-90 days |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
study is conducted completely via review of electronic health records. Our site will only collect data from the Methodist Dallas Medical Center.
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Crystee Cooper, DHEd | Contact | 214-947-1280 | ClinicalResearch@mhd.com | |
| Ashley Haider | Contact | 214-947-1280 | ClinicalResearch@mhd.com |
| Name | Affiliation | Role |
|---|---|---|
| Michael Truitt, M.D. | The Methodist Hospital Research Institute | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Methodist Dallas Medical Center | Recruiting | Dallas | Texas | 75203 | United States |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D009336 | Necrosis |
| ID | Term |
|---|---|
| D010335 | Pathologic Processes |
| D013568 | Pathological Conditions, Signs and Symptoms |
Not provided
Not provided
Not provided
Not provided
Not provided